Continuous industrial consumption of trichloromethane, CAS 67-66-3, outside laboratory reagent markets is dominated by acid-grade feedstock supplied to chlorodifluoromethane plant trains. At integrated fluorochemical sites, anhydrous hydrogen fluoride is transferred through pressure-rated Monel or Hastelloy C-276 lines into a stirred liquid-phase fluorination vessel containing antimony pentachloride at a molar ratio of HF to CHCl₃ deliberately maintained above the stoichiometric 2.00:1 value—usually within 2.05:1 to 2.25:1—so that chloroform is consumed before the hydrogen chloride stream leaves the reactor. The reactor operates at 80–130 °C and 0.7–1.2 MPa, with heat removal from the exothermic substitution handled by internal coils and an external recirculation loop through a cooled shell-and-tube exchanger. Crude chlorodifluoromethane is then water-scrubbed, caustic-scrubbed, dried over molecular sieves, compressed, and routed to a low-temperature distillation train. Refrigerant-grade R-22 is tested against AHRI 700-2019 specifications for purity, moisture, acidity, and high-boiling residue; feedstock material for tetrafluoroethylene monomer production is commonly specified at purity above 99.9% with CHCl₃ residual below 50 mg/kg. For fluoropolymer feed, the chlorodifluoromethane stream is thermally cracked at 700–900 °C in steam-diluted tubular reactors to yield tetrafluoroethylene, which is then scrubbed, stabilised, and polymerised under suspension or dispersion conditions. The regulatory boundary is split: refrigerant end uses are subject to Montreal Protocol phase-out schedules and licensing under national ozone-depleting substance legislation, whereas feedstock exemptions permit continued chlorodifluoromethane consumption for tetrafluoroethylene monomer when conversion records and usage reporting are maintained to the satisfaction of the relevant authority. Under REACH Regulation (EC) No 1907/2006, placing chloroform on the market as a substance or in mixtures for supply to the general public is restricted; industrial and laboratory uses are covered by the registration dossier and downstream user chemical safety reports. The primary process limitation is moisture ingress, which hydrolyses the antimony catalyst and generates hydrogen chloride corrosion; combined feed streams are therefore dried to low-moisture specifications, and online hydrogen chloride monitors are positioned at the crude gas outlet.

Within the same integrated plant, the fluoropolymer-grade chlorodifluoromethane stream is handled separately from refrigerant-grade material because the presence of trace stabilisers or lubricants from compressed gas systems can poison the thermal cracking catalyst. The cracking furnace tubes are commonly fabricated from Incoloy 800H or Inconel 625 and are operated at 700–900 °C with steam dilution at a steam-to-chlorodifluoromethane molar ratio between 3:1 and 8:1; shorter residence times at the upper temperature band raise tetrafluoroethylene selectivity and reduce hexafluoroethane formation. The cracked gas is quenched with cooled acidified water, compressed, and passed through a silica gel drier before tetrafluoroethylene monomer is polymerised. At this point the application path changes from solvent chemistry to polymer synthesis; the quality of the monomer is verified by gas chromatography for tetrafluoroethylene purity above 99.99% and by oxygen and carbon dioxide limits below 10 µL/L. The polymerisation vessel is then charged with high-purity water, ammonium persulfate or peroxide initiator, and optionally a fluorinated surfactant; the reaction is run at 65–80 °C and 2.0–2.5 MPa. End products are polytetrafluoroethylene fine powders, granular moulding resins, or aqueous dispersions used in wire insulation, chemical linings, and high-temperature seals. Equipment failure modes observed on production lines include premature erosion of the agitator impeller at the liquid-vapour interface when the HF/CHCl₃ ratio falls below 2.00:1, localised pitting of carbon steel downstream of the acid scrubber if caustic neutralisation is delayed, and oligomer formation in the tetrafluoroethylene unit when water or dry ice enters the cracked gas line. Batch-to-batch variation in crude fluorocarbon purity is reduced by continuous feed metering rather than batch charging, with variable-frequency drives on the HF and CHCl₃ feed pumps maintaining flow constancy within ±0.5%. The section is designed as an isolated process cell with emergency pressure relief to a caustic vent scrubber under 29 CFR 1910.119 process safety management jurisdiction.

What Limits Residual Chloroform in Oral Solid Dose Manufacturing?

Trichloromethane retains a narrow extraction role in active pharmaceutical ingredient purification when alternative halogenated solvents such as dichloromethane cannot achieve the required selectivity for alkaloid or macrocyclic intermediates. Under ICH Q3C (R8), chloroform is assigned to Class 2 with a permissible daily exposure of 0.6 mg/day and a concentration limit of 60 ppm in oral drug products. Plant-scale extraction typically charges 5–8 parts by mass chloroform per 1 part dry crude extract; the biphasic mixture is stirred under nitrogen in a glass-lined reactor below 25 °C, discharged to a bottom-settling centrifuge, and the lower organic phase is concentrated in a wiped-film evaporator at 60–80 °C jacket temperature and 25–35 kPa vacuum. The separating solvent must not contain stabilisers that would become a new primary contaminant; therefore technical-grade material is often redistilled or purchased as stabiliser-free grade with a non-volatile residue specification below 5 mg/kg. The critical compliance step is residual solvent removal from the wet granulation or from amorphous spray-dried intermediates, because bound chloroform in lactose or copovidone matrices is removed more slowly than free solvent and can exceed the 60 ppm release threshold if drying time is shortened. Release testing is normally performed by headspace gas chromatography according to USP Chapter 467 or an equivalent pharmacopoeial method, with quantitation against a matrix-matched calibration curve and a limit of quantitation not higher than 10 ppm.

Operational boundaries are set by the fact that chloroform is a Class 2 solvent; a manufacturing process that cannot demonstrate drying to below the PDE-derived limit will not receive marketing authorisation for major pharmacopoeial markets. Equipment contact materials are limited to glass-lined steel, PTFE gaskets, and 316L stainless steel for short transfer lines, because chlorinated solvents leach plasticizers from standard elastomer seals and can create non-visible particulate contamination. In campaigns where chloroform is used for extraction, the cleaning validation protocol must include a solvent-specific swab recovery study, because chloroform residues are not reliably removed by a standard purified-water flush after drying. The exposure control requirement is similarly constrained: open extraction vessels are placed behind local exhaust ventilation with a minimum face velocity of 0.5 m/s, and maintenance tasks on the wiped-film evaporator require pre-entry solvent vapour monitoring because chloroform is denser than air and accumulates in low points of the process cell.

When Substituted Phenols Are Formylated via Dichlorocarbene Attack

In fine chemical synthesis, trichloromethane acts as a carbene precursor under strongly alkaline biphasic conditions. A common plant recipe combines 1.0 mol of phenolic substrate with 2.0–2.5 mol CHCl₃ and 4.0–6.0 mol sodium hydroxide in a water-ethanol phase held at 55–65 °C; dichlorocarbene generated at the interface inserts into the ortho position of the phenoxide. Reactor size is conventionally limited to 10 m³ because the exothermic decomposition of chloroform in contact with hot caustic can escalate; the chloroform charge is therefore made below 30 °C, the mass is heated under continuous agitation, and the vessel is vented through a caustic scrubber to neutralise carbon monoxide and formic acid byproducts. The resulting substituted salicylaldehydes are recovered by steam distillation, acidification, and vacuum redistillation. End products include fragrance intermediates, chelating ligands, and selected agrochemical actives. The process is incompatible with nitro-substituted phenols because concentrated alkali combined with hot chloroform can trigger uncontrolled decomposition; published data for this specific configuration is limited, but differential scanning calorimetry screening under ASTM E537-20 is generally used to establish a thermal stability boundary before scale-up.

Continuous industrial execution of Reimer-Tiemann reactions has mostly moved to campaign mode in multi-purpose fine chemical plants; batch records require the water-ethanol phase to be sampled for free alkalinity before chloroform addition because pH below 13 slows dichlorocarbene generation and leads to tar formation. The distillate receiver is kept under nitrogen, and the aqueous mother liquor is oxidatively treated to destroy residual chloroform before biotreatment. A secondary side reaction is the formation of benzaldehyde derivatives from hydrolysis of the intermediate dichloromethyl phenol; therefore the reaction mass is quenched as soon as the substrate is consumed, with a maximum hold time after heat-off of 30 minutes in order to protect yield. Terminal products are shipped as pure salicylaldehydes with assay by GC not less than 99.0% and a chloroform residual below 10 mg/kg for fragrance-grade material.

Deuterated trichloromethane is manufactured by H/D exchange of high-purity chloroform with deuterium oxide under basic pressure conditions, followed by neutralisation, drying, and fractional distillation to a deuteration degree of at least 99.8 atom% D. NMR laboratories purchase the material in 10 mL glass ampoules or 100 g bottles with 0.03–0.10% v/v tetramethylsilane added as an internal chemical shift reference. The solvent must pass a near-infrared water check not exceeding 0.01% w/w, because residual water broadens exchangeable proton signals and reduces signal-to-noise ratio for dilute samples in 5 mm tubes. The primary downstream terminal use is sample preparation for ¹H, ¹³C, and 2D NMR structure elucidation of synthetic intermediates, natural products, and polymer end-groups. A typical loading for a 5 mm NMR tube is 0.5–0.7 mL, with sample concentrations of 5–20 mg/mL adjusted so that the residual solvent signal at δ 7.26 ppm in ¹H does not obscure aromatic protons. Operational limitations include photochemical formation of phosgene under prolonged UV exposure and the need for amber-glass storage below 4 °C. The largest batch-to-batch concern is water regain after ampoule opening; once opened, a bottle is normally placed over activated 4 Å molecular sieves and kept in a desiccator under nitrogen.

In food testing and biomedical research, a biphasic chloroform-methanol partition remains a reference method for isolating total lipids from wet tissue and complex feed matrices. The extraction follows the Folch principle: homogenised sample is mixed with a 2:1 v/v chloroform-methanol mixture, then washed with 0.2 volumes of water or 0.88% w/v sodium chloride solution to separate the lower chloroform-rich phase. The lower phase is drained through anhydrous sodium sulfate into a tared flask and evaporated on a rotary evaporator at 40 °C under reduced pressure. The residue is then used for gravimetric lipid content determination or derivatised to fatty acid methyl esters according to ISO 12966-2:2017 and analysed by gas chromatography with flame ionisation detection. This application is confined to analytical laboratories because chloroform is not acceptable in direct food processing; the method is selected only when chloroform-resistant glass centrifuge tubes, PTFE-lined caps, and fume hoods with a minimum face velocity of 0.5 m/s are available. A known operational limitation is the formation of a protein interphase in samples with high phospholipid content; re-extraction of the interphase with fresh 2:1 mixture is required to obtain complete lipid recovery. Published data for specific configurations of low-fat wet tissue is limited, and method recovery is therefore verified by spiking with a triglyceride internal standard and running a matrix blank with each batch.